BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 50 filers reported holding BIOTA PHARMACEUTIALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $161,000 | -43.7% | 107,599 | -26.9% | 0.00% | -50.0% |
| Q4 2015 | $286,000 | -5.6% | 147,281 | -3.9% | 0.01% | 0.0% |
| Q3 2015 | $303,000 | +2.0% | 153,181 | +6.7% | 0.01% | 0.0% |
| Q2 2015 | $297,000 | -13.4% | 143,569 | -3.6% | 0.01% | 0.0% |
| Q1 2015 | $343,000 | – | 148,969 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 1,617,500 | $3,348,000 | 0.58% |
| Broadfin Capital, LLC | 2,611,711 | $5,406,000 | 0.29% |
| RA Capital Management | 807,855 | $1,672,000 | 0.17% |
| TOWERVIEW LLC | 160,000 | $331,000 | 0.16% |
| BVF INC/IL | 350,776 | $726,000 | 0.13% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 292,807 | $606,000 | 0.09% |
| Koshinski Asset Management, Inc. | 27,200 | $28,180,000 | 0.02% |
| Baker Brothers Advisors | 830,440 | $1,719,000 | 0.02% |
| KNOTT DAVID M | 31,833 | $65,894,000 | 0.01% |
| SHEPHERD KAPLAN KROCHUK, LLC | 26,756 | $55,000 | 0.01% |